Somatostatin and counterregulatory hormone responses to hypoglycaemia in diabetics with and without autonomic neuropathy.
Blood glucose, somatostatin and counterregulatory hormone responses to an i.v. bolus of insulin were studied in insulin-dependent diabetics with different degrees of autonomic neuropathy, after 24 hours of optimised control with an artificial pancreas. There was no plasma catecholamine response in patients with a sympathetic autonomic neuropathy. A normal somatostatin response to hypoglycemia was absent in patients with autonomic neuropathy. Glucagon did not respond in diabetics, independently of the degree of neuropathy. In all diabetics, cortisol and GH were stimulated. Absence of warning symptoms was observed in patients with catecholamine deficiency. Despite different hormone behaviour, blood glucose fall and recovery were similar in all diabetic groups. It is concluded that the glucagon response to insulin hypoglycaemia is reduced in all type 1 longstanding diabetics, whereas catecholamine and somatostatin responses are only abolished in those with autonomic neuropathy. Patients with sympathetic neuropathy would be considered at increased risk severe hypoglycaemia.
Fernandez-Castaner
M
M
Webb
S
S
Levy
I
I
Rios
M
M
Casamitjana
R
R
Bergua
M
M
Figuerola
D
D
Rivera
F
F
D000328:Adult; D001342:Autonomic Nervous System Diseases / Q000097:blood*; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000097:blood*; D004837:Epinephrine / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood; D006801:Humans; D007003:Hypoglycemia / Q000097:blood* / Q000139:chemically induced; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D009638:Norepinephrine / Q000097:blood; D013004:Somatostatin / Q000097:blood
D001786:Blood Glucose; D007328:Insulin; D013004:Somatostatin; D005934:Glucagon; D009638:Norepinephrine; D004837:Epinephrine